Insider trades

David R.W. Jayne, Director of Aurinia Pharmaceuticals AUPH, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/11/21.

David R.W. Jayne

Director
First filing
23/05/23
Trades
8 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
24/11/21

Trading activity

Transactions

Trade type
Open-market sale24/05/2124/05/224,946 sh$5.74$28,390.04−10.0%
Open-market sale23/05/2323/05/238,733 sh$11.26$98,333.58−15.0%